PIPA5102035

CD264 (TRAIL-R4) Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5102035-Each-of-1 In Stock ₹ 46,502.50

PIPA5102035 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

CD264 (TRAIL-R4)

Classification

Polyclonal

Conjugate

Unconjugated

Gene

TNFRSF10D

Gene Alias

CD264; DCR2; Decoy receptor 2; TNF receptor superfamily member 10d; TNF receptor-related receptor for TRAIL; TNF-related apoptosis-inducing ligand receptor 4; TNFRSF10D; TRAIL receptor 4; TRAIL receptor with a truncated death domain; TRAILR4; TRAIL-R4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; tumor necrosis factor receptor superfamily member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; UNQ251/PRO288

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

8793

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

Q9UBN6

Gene Symbols

TNFRSF10D

Immunogen

A synthesized peptide derived from human TNFRSF10D(Accession Q9UBN6), corresponding to amino acid residues K122-C172.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIMA531248

--

Img

Novus Biologicals

NP270378A30

--

Img

Novus Biologicals

NBP270378G

--

Img

Thermo Scientific

PIMA548036

--

Img

Novus Biologicals

NB502717

--

Img

Novus Biologicals

NB370137

--

Img

Novus Biologicals

NBP250284C

--

Img

Novus Biologicals

NBP250284FR

--

Description

  • Antibody detects endogenous levels of total TNFRSF10D
  • TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines
  • A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis
  • Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression
  • The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.